BenzingaOctober 13, 2026 at 8:40 AM NY14 Days Ago
TD Cowen Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $420
TD Cowen analyst Brendan Smith maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $410 to $420.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
